Page 44 - GHES-2-2

Global Health Econ Sustain MDR-TB and the road ahead

Ou, Z.J., Yu, D.F., Liang, Y.H., He, W.Q., Li, Y.Z., Meng, Y.X., et al. Khan, M.H.R., Ahmed, S., et al. (2021). HIV infection and
(2021). Trends in burden of multidrug-resistant tuberculosis multidrug resistant tuberculosis: A systematic review and
in countries, regions, and worldwide from 1990 to 2017: meta-analysis. BMC Infectious Diseases, 21(1):51.
Results from the Global Burden of Disease study. Infectious https://doi.org/10.1186/s12879-020-05749-2
Diseases of Poverty, 10(1):24.
Suppli, C.H., Norman, A., Folkvardsen, D.B., Gissel, T.N.,
https://doi.orgg/10.1186/s40249-021-00803-w Weinreich, U.M., Koch, A., et al. (2022). First outbreak of
Riccardi, N., Canetti, D., Martini, M., Diaw, M.M., DI Biagio, A., multidrug-resistant tuberculosis (MDR-TB) in Denmark
Codecasa, L., et al. (2020). The evolution of a neglected involving six Danish-born cases. International Journal of
disease: Tuberculosis discoveries in the centuries. Journal of Infectious Diseases, 117:258-263.
Preventive Medicine and Hygiene, 61(1):E9-E12. https://doi.org/10.1016/j.ijid.2022.02.017
https://doi.org/10.15167/2421-4248/jpmh2020.61.1s1.1353 Tanimura, T., Jaramillo, E., Weil, D., Raviglione, M., &
Rockwood, N., Du Bruyn, E., Morris, T., & Wilkinson, R.J. (2016). Lönnroth, K. (2014). Financial burden for tuberculosis
Assessment of treatment response in tuberculosis. Expert patients in low- and middle-income countries: A systematic
Review of Respiratory Medicine, 10(6):643-654. review. European Respiratory Journal, 43(6):1763-1775.
https://doi.org/10.1586/17476348.2016.1166960 https://doi.org/10.1183/09031936.00193413
Saderi, L., Cabibbe, A.M., Puci, M., Di Lorenzo, B., Centis, R., United Nations. (2018). High Level Meeting on the Fight
Pontali, E., et al. (2023). A systematic review of the costs of Against Tuberculosis. New York, USA: United Nations
diagnosis for multidrug-resistant/extensively drug-resistant Publications. Available from: https://cdn.who.int/
TB in different settings. The International Union Against media/docs/default-source/documents/tuberculosis/
Tuberculosis and Lung Disease, 27(5):348-356. political-declaration-un-general-assembly-tb-
tuberculosis77cd7a27-7e8d-4fbb-9729-a5dbd505798f.
https://doi.org/10.5588/ijtld.22.0657 pdf?sfvrsn=4f4090dc_1&download=true [Last accessed on
Seijger, C., Hoefsloor, W., Bergsma-de Guchteneire, I., Te 2024 Jan 26].
Brake, L., van Ingen, J., Kuipers, S., et al. (2019). High- Van den Hof, S., Collins, D., Hafidz, F., Beyene, D.,
dose rifampicin in tuberculosis: Experiences from a Dutch Tursynbayeva, A., & Tiemersma, E. (2016). The
tuberculosis centre. PLoS One, 14(3):e0213718. socioeconomic impact of multidrug resistant tuberculosis on
https://doi.org/10.1371/journal.pone.0213718 patients: rEsults from Ethiopia, Indonesia and Kazakhstan.
BMC Infectious Diseases, 16(1):470.
Sinha, P., Jacobson, K.R., Horsburgh, C.R. Jr., & Acuña-
Villaorduña, C. (2023). At long last: Short, all-oral regimes https://doi.org/10.1186/s12879-016-1802-x
for multidrug-resistant Tuberculosis in the United States. Van Rie, A., Walker, T., de Jong, B., Rupasinghe, P., Rivière, E.,
Open Forum Infectious Diseases, 10(4):ofad177. Dartois, V., et al. (2022). Balancing access to BPaLM
https://doi.org/10.1093/ofid/ofad177 regimens and risk of resistance. Lancet Infectious Diseases,
22(10):1411-1412.
Stop TB Partnership. (2023). Stop TB’s Global Drug Facility
Announces Historic Price Reductions up to 55% for https://doi.org/10.1016/S1473-3099(22)00543-6
Bedaquiline, a Life-Saving Drug to Treat Drug-Resistant TB. World Health Organization. (2014). Companion Handbook to
Geneva: Stop TB Partnership. Available from: https://www. the WHO Guidelines for the Programmatic Management of
stoptb.org/news/stop-tbs-global-drug-facility-announces- Drug-Resistant Tuberculosis. Available from: https://www.
historic-price-reductions-to-55-bedaquiline-life-saving ncbi.nlm.nih.gov/books/NBK247432 [Last accessed on
[Last accessed on 2024 Jan 24]. 2024 Jan 25].
Storla, D.G., Yimer, S., & Bjune, G.A. (2008). A systematic review World Health Organization. (2015). The End TB Strategy.
of delay in the diagnosis and treatment of tuberculosis. BMC Available from: https://who-htm-tb-2015.19-eng.pdf [Last
Public Health, 8:15. accessed on 2024 Jan 20].
https://doi.org/10.1186/1471-2458-8-15 World Health Organization. (2021). Global Tuberculosis Report
2021. Available from: https://iris.who.int/bitstream/han
Subbaraman, R., de Mondesert, L., Musiimenta, A., Pai, M.,
Mayer, K.H., Thomas, B.E., et al. (2018). Digital adherence dle/10665/346387/9789240037021-eng.pdf?sequence=1
technologies for the management of tuberculosis therapy: [Last accessed on 2024 Jan 20].
Mapping the landscape and research priorities. BMJ Global World Health Organization. (2021). WHO Consolidated
Health, 3(5):e001018. Guidelines on Tuberculosis. Module 3: Diagnosis - Rapid
Diagnostics for Tuberculosis Detection, 2021 Update.
https://doi.org/10.1136/bmjgh-2018-001018
Available from: https://iris.who.int/bitstream/han
Sultana, Z.Z., Ul Hoque, F., Beyene, J., Akhlak-Ul-Islam, M., dle/10665/376221/9789240089488-eng.pdf?sequence=1

Volume 2 Issue 2 (2024) 7 https://doi.org/10.36922/ghes.2876